A study of the use of sedative PRN medication in patients at a secure hospital

References

• Baker, J.A., Lovell, K., & Harris, N. (2008). A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings. Journal of Clinical Nursing, 17, 1122–1131.
   PubMed Web of Science ®Google Scholar
• Blom, M.T., Bardai, A., van Munster, B.C., Nieuwland, M., de Jong, H., van Hoeijen, D.A., … Tan, H.L. (2011). Differential changes in QTc duration during in-hospital haloperidol use. PLoS ONE, 6, e23728. doi:10.1371/journal.pone.002372810.1371/journal.pone.0023728
   Google Scholar
• British Medical Association and Royal Pharmaceutical Society. (2013). British National Formulary No. 66. London: BMJ Group and Pharmaceutical Press.
   Google Scholar
• Chakrabarti, A., Whicher, E.V., Morrison, M., & Douglas-Hall, P. (2007). ‘As required’ medication regimens for seriously mentally ill people in hospital. Cochrane Database of Systematic Reviews 2007, (3), Art. No.: CD003441. doi:10.1002/14651858.CD003441.pub2
   Web of Science ®Google Scholar
• Craig, T., & Bracken, J. (1995). An epidemiologic study of prn/stat medication use in a state psychiatric hospital. Annals of Clinical Psychiatry, 7, 57–64.10.3109/10401239509149028
   PubMedGoogle Scholar
• Craven, J.L., Voore, P.M., & Voineskos, G. (1987). PRN medication for psychiatric inpatients. Canadian Journal of Psychiatry, 32, 199–203.
   PubMed Web of Science ®Google Scholar
• Curtis, J., & Capp, K. (2003). Administration of ‘as needed’ psychotropic medication: A retrospective study. International Journal of Mental Health Nursing, 12, 229–234.10.1046/j.1440-0979.2003.00293.x
   PubMed Web of Science ®Google Scholar
• Davies, S.J.C., Lennard, M.S., Ghahramani, P., Pratt, P., Robertson, A., & Potokar, J. (2007). PRN prescribing in psychiatric inpatients – Potential for pharmacokinetic drug interactions. Journal of Psychopharmacology, 21, 153–160.10.1177/0269881107067242
   PubMed Web of Science ®Google Scholar
• Hales, H., & Gudjonsson, G.H. (2004). Effect of ethnic differences on the use of prn (as required) medication on an inner London medium secure unit. Journal of Forensic Psychiatry and Psychology, 15, 303–313.10.1080/14789940410001702049
   Web of Science ®Google Scholar
• Haw, C., & Stubbs, J. (2011). Medication for borderline personality disorder: A survey as a secure hospital. International Journal of Psychiatry in Clinical Practice, 15, 280–285.
   PubMed Web of Science ®Google Scholar
• IBM Corporation. (2011). IBM SPSS statistics for Windows (Version 20.0). New York, NY: Author.
   Google Scholar
• Lelliott, P., Paton, C., Harrington, M., Konsolaki, M., Sensky, T., & Okocha, C. (2002). The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 411–414.10.1192/pb.26.11.411
   Google Scholar
• McLaren, S., Browne, F.W., & Taylor, P.J. (1990). A study of psychotropic medication given ‘as required’ in a regional secure unit. The British Journal of Psychiatry, 156, 732–735.10.1192/bjp.156.5.732
   PubMed Web of Science ®Google Scholar
• Milton, J., Lawton, J., Smith, M., & Buckley, A. (1998). Hidden high-dose antipsychotic prescribing: Effects of p.r.n. doses. Psychiatric Bulletin, 22, 675–677.10.1192/pb.22.11.675
   Google Scholar
• National Institute for Health and Clinical Excellence. (2005). The short-term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments. London: Royal College of Nursing.
   Google Scholar
• National Institute for Health and Clinical Excellence CG78. (2009). Borderline personality disorder: Treatment and management. London: British Psychological Society and Royal College of Psychiatrists.
   Google Scholar
• Paton, C., Barnes, T.R.E., Cavanagh, M.R., Taylor, D., & Lelliott, P. (2008). High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing. The British Journal of Psychiatry, 192, 435–439.10.1192/bjp.bp.107.042895
   PubMed Web of Science ®Google Scholar
• Smith, G.M., Davis, R.H., Altenor, A., Tran, D.P., Wolfe, K.L., Deegan, J.A., & Bradley, J. (2008). Psychiatric use of unscheduled medications in the Pennsylvania state hospital system: Effects of discontinuing the use of P.R.N. orders. Community Mental Health Journal, 44, 261–270.10.1007/s10597-008-9126-y
   PubMed Web of Science ®Google Scholar
• Srivastava, A. (2009). Limited evidence for the effectiveness of P.R.N. medications among psychiatric inpatients. Journal of Psychiatric Practice, 15, 193–201.
   PubMed Web of Science ®Google Scholar
• Stewart, D., Robson, D., Chaplin, R., Quirk, A., & Bowers, L. (2012). Behavioural antecedents to pro re nata psychotropic medication administration on acute psychiatric wards. International Journal of Mental Health Nursing, 21, 540–549.10.1111/inm.2012.21.issue-6
   PubMed Web of Science ®Google Scholar
• Thapa, P.B., Palmer, S.L., Owen, R.R., Huntley, A.L., Clardy, J.A., & Miller, L.H. (2003). P.R.N. (as-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications. Psychiatric Services, 54, 1282–1286.
   PubMed Web of Science ®Google Scholar
• Usher, K., Lindsay, D., & Sellen, J. (2001). Mental health nurses’ PRN psychotropic medication administration practices. Journal of Psychiatric and Mental Health Nursing, 8, 383–390.10.1046/j.1365-2850.2001.00407.x
   PubMedGoogle Scholar
• Walker, R. (1991). PRN psychotropic drug use on a psychiatric unit. Psychiatric Quarterly, 62, 1–8.
   PubMedGoogle Scholar
• Yorston, G., & Pinney, A. (2000). Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin, 24, 130–132.10.1192/pb.24.4.130
   Google Scholar